... , S.D. (2008), “ Recognizing consumer issues in DTC pharmaceutical advertising ”, The Journal of Consumer Affairs , Vol. 42 , Spring , pp. 60 ‐ 80 . © Emerald Group Publishing Limited 2009 Pharmaceuticals industry Advertising Consumer marketing Medical products The most...

... and 65 years old, the percentage increases to 21.6 per cent, and for people older than 65 years to 23.9 per cent. © Emerald Group Publishing Limited 2005 Pharmaceuticals industry Consumer psychology Marketing strategy Internet An executive summary for managers and executive readers...

... limitations/implications This is a descriptive framework that has not been validated for its use in the pharmaceutical market. Practical implications Offers a useful framework for academics, managers, students, and individuals to classify and study developments in the pharmaceutical industry...

...Greg Finlayson; Ross Mullner Purpose The purpose of this paper is to review the issues regarding direct‐to‐consumer advertising that have been identified in the literature from the perspective of consumers, consumer groups, physicians, the medical profession and the pharmaceutical industry...

... Pharmaceuticals industry Prescription medicines An executive summary for managers and executive readers can be found at the end of this issue. While advertising expenditures continue to grow every year in the USA, marketers, executives, policy makers, academics, and the general public continue to debate...

... Limited 2005 Pharmaceuticals industry Drugs Brand names Regardless of the consumer protection problem described in our term papers, the students in our 1975 graduate marketing and society course mentioned “consumer information” as a major part of the solution. Misprescribed pharmaceuticals...

... Emerald Group Publishing Limited 2004 Small to medium‐sized enterprises Market position Value added Value chain Pharmaceuticals industry United Kingdom In the case of therapeutic drugs, these trials are organised in a series of successive sub‐stages: After a discussion...

...Herbert Jack Rotfeld Looks at the use of brand names in the pharmaceutical industry in comparison with generic versions. Gives a brief history of brand name development. Concludes that brand names for pharmaceutical drugs should be banned since this is open to abuse in the area of cost enhancement...